Collaboration. Acceleration. Results.      1 877 TO FIX MS
Myelin Repair Foundation Home Page Donate to Myelin Repair Foundation
Mission: To transform the way all medical research is done — ensuring research results in real patient treatments in the shortest amount of time.

Our Research Model

We are the only research organization that addresses every phase in the drug discovery process, from initial research all the way to the clinic, in order for new treatments to reach patients.

The Myelin Repair Foundation's Accelerated Research Collaboration™ (ARC™) model addresses every phase in the drug discovery continuum, from initial research all the way to licensing by commercial drug developers. Through the Myelin Repair Foundation’s ongoing management oversight, the ARC model optimizes and integrates the contributions of all those who participate in the value chain of making new medicines.

As a result, the Myelin Repair Foundation’s ARC model:

  • Provides an increased number of therapeutically relevant treatment targets in the pipeline
  • Translates discoveries made in animal models to the human system
  • Builds partnerships with biopharma companies to develop and bring new drugs to market and
  • Results in quicker, effective treatments for millions of patients living with chronic diseases, improving their quality of life

The Accelerated Research Collabortation™ (ARC™) Model

Click each section to learn more about the Myelin Repair Foundation's ARC model. To read more, visit these pages: Discovery Biology | Translational Medicine Platform | Clinical Development

Patient Outcomes
Clinical Development
Clinical Development
Clinical Development
Translational Medicine Platform
Translational Medicine Platform
Translational Medicine Platform
Discovery Biology
Discovery Biology
Discovery Biology

What Others are Saying

“[Myelin Repair Foundation's] goal of entering into clinical trials by 2014 is admittedly ambitious, but they are aided by their reliance on collaboration in its truest form—the open sharing of information and ideas with the hope of expelling the suffering caused by MS.”

Drug Discovery News
March 2012

JOIN US

Support Our Clinical Trial Campaign

Our goal is to raise $200,000 online by June 2014 to help cover a portion of the MRF-008 trial cost. Donations at all levels are critical to this effort.

Donate Now

Keep Updated On Our Progress

Sign Up for Email Updates